Y-Box Binding Protein-1 Promotes Epithelial-Mesenchymal Transition in Sorafenib-Resistant Hepatocellular Carcinoma Cells

Hepatocellular carcinoma is one of the most common cancer types worldwide. In cases of advanced-stage disease, sorafenib is considered the treatment of choice. However, resistance to sorafenib remains a major obstacle for effective clinical application. Based on integrated phosphoproteomic and The C...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Li-Zhu, Chen, Chih-Ta, Li, Nien-Chen, Lin, Liang-Chun, Huang, Bo-Shih, Chang, Ya-Hui, Chow, Lu-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795419/
https://www.ncbi.nlm.nih.gov/pubmed/33379356
http://dx.doi.org/10.3390/ijms22010224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795419/
https://www.ncbi.nlm.nih.gov/pubmed/33379356
http://dx.doi.org/10.3390/ijms22010224

Ejemplares similares